AdaptHealth (NASDAQ:AHCO) Shares Up 8.3% After Insider Buying Activity

AdaptHealth Corp. (NASDAQ:AHCO)’s stock price traded up 8.3% during trading on Tuesday after an insider bought additional shares in the company. The stock traded as high as $11.13 and last traded at $11.2350. 450,296 shares were traded during mid-day trading, a decline of 64% from the average session volume of 1,247,154 shares. The stock had previously closed at $10.37.

Specifically, major shareholder Richard M. Cashin, Jr. bought 447,100 shares of AdaptHealth stock in a transaction on Friday, March 20th. The stock was acquired at an average cost of $9.91 per share, with a total value of $4,430,761.00. Following the completion of the acquisition, the insider owned 16,312,698 shares in the company, valued at approximately $161,658,837.18. This represents a 2.82% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Royal Bank Of Canada reiterated an “outperform” rating and set a $13.00 price target on shares of AdaptHealth in a research note on Wednesday, February 25th. Zacks Research upgraded AdaptHealth from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Weiss Ratings cut AdaptHealth from a “hold (c-)” rating to a “sell (d)” rating in a report on Wednesday, February 25th. Wall Street Zen downgraded AdaptHealth from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. Finally, Leerink Partners cut their price target on AdaptHealth from $13.00 to $12.00 and set an “outperform” rating for the company in a report on Thursday, February 26th. Four research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, AdaptHealth currently has an average rating of “Moderate Buy” and an average target price of $13.25.

Key Stories Impacting AdaptHealth

Here are the key news stories impacting AdaptHealth this week:

• Positive Sentiment: Major insider buy — Richard M. Cashin Jr., a >10% holder, purchased 447,100 shares (~$4.43M) at about $9.91 per share, increasing his stake and signaling insider confidence in the business. Insider Buying: AdaptHealth Major Shareholder Purchases 447,100 Shares
• Positive Sentiment: Technical/momentum lift — several outlets report AHCO surged to a new 12‑month high and registered strong relative strength, which attracts momentum traders and ETFs that use RS screens. AdaptHealth Surges To New High
• Positive Sentiment: Institutional accumulation highlighted — reports show several hedge funds/institutions have been increasing positions in AHCO, supporting longer-term demand and liquidity (MarketBeat coverage). AdaptHealth Institutional Ownership & Coverage
• Neutral Sentiment: Analyst picture is mixed — consensus is a “Moderate Buy” with an average target around $13.25, but recent rating/price target tweaks are varied, so analyst action is not uniformly bullish. Analyst Ratings Summary
• Negative Sentiment: Zacks caution — Zacks flagged a 10.7% surge on above‑average volume but noted that recent earnings‑estimate revision trends don’t support sustained upside, implying the rally could be partly technical rather than fundamental. Zacks: AHCO Surges 10.7%
• Negative Sentiment: Rising short interest — reports show a notable increase in short positions in March (~9.04M shares in one report, ≈6.8% of float, ~5.1 days to cover), which can pressure the stock if fundamentals disappoint but also raises squeeze potential during rallies. (Short interest data aggregated from recent filings/reports.)

AdaptHealth Trading Down 0.8%

The firm has a market capitalization of $1.55 billion, a P/E ratio of -20.71, a price-to-earnings-growth ratio of 1.32 and a beta of 1.76. The stock’s 50-day simple moving average is $10.13 and its two-hundred day simple moving average is $9.75. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.02 and a quick ratio of 0.81.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings data on Tuesday, February 24th. The company reported ($0.76) EPS for the quarter, missing the consensus estimate of $0.34 by ($1.10). AdaptHealth had a negative net margin of 2.18% and a positive return on equity of 3.42%. The firm had revenue of $846.29 million for the quarter, compared to the consensus estimate of $832.51 million. During the same quarter in the previous year, the business earned $0.34 earnings per share. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. Equities research analysts expect that AdaptHealth Corp. will post 0.88 EPS for the current year.

Institutional Investors Weigh In On AdaptHealth

A number of institutional investors have recently bought and sold shares of the business. Rockefeller Capital Management L.P. lifted its position in shares of AdaptHealth by 433.0% in the fourth quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock valued at $26,000 after acquiring an additional 2,100 shares in the last quarter. FNY Investment Advisers LLC bought a new position in shares of AdaptHealth in the third quarter worth about $35,000. PNC Financial Services Group Inc. raised its stake in AdaptHealth by 22.3% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock valued at $70,000 after purchasing an additional 1,279 shares during the period. Tower Research Capital LLC TRC raised its stake in AdaptHealth by 318.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock valued at $90,000 after purchasing an additional 7,297 shares during the period. Finally, Tidal Investments LLC bought a new stake in AdaptHealth during the 2nd quarter valued at approximately $96,000. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.